Prognostic value of interferon-γ release assays and tuberculin skin test in predicting the development of active tuberculosis (UK PREDICT TB): a prospective cohort study.

The Lancet Infectious Diseases
Ibrahim AbubakarPREDICT Study Team

Abstract

Tackling tuberculosis requires testing and treatment of latent tuberculosis in high-risk groups. The aim of this study was to estimate the predictive values of the tuberculin skin test (TST) and two interferon-γ release assays (IGRAs) for the development of active tuberculosis in high-risk groups-ie, people in recent contact with active tuberculosis cases and from high-burden countries. In this prospective cohort study, we recruited participants from 54 centres (eg, clinics, community settings) in London, Birmingham, and Leicester in the UK. Participants were eligible if they were aged 16 years or older and at high risk for latent tuberculosis infection (ie, recent contact with someone with active tuberculosis [contacts] or a migrant who had arrived in the UK in the past 5 years from-or who frequently travelled to-a country with a high burden of tuberculosis [migrants]). Exclusion criteria included prevalent cases of tuberculosis, and participants who were treated for latent tuberculosis after a positive test result in this study. Each participant received three tests (QuantiFERON-TB Gold-In Tube, T-SPOT.TB, and a Mantoux TST). A positive TST result was reported using three thresholds: 5 mm (TST-5), 10 mm (TST-10), and greater ...Continue Reading

Citations

Jan 29, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Matthew P ChengFrancisco M Marty
Jul 4, 2019·American Journal of Public Health·Margaret Kruse, William Cruikshank
Nov 13, 2019·American Journal of Respiratory and Critical Care Medicine·Jason E StoutPatrick P J Phillips
Dec 10, 2019·American Journal of Respiratory and Critical Care Medicine·Ibrahim AbubakarMolebogeng X Rangaka
Dec 12, 2019·American Journal of Respiratory and Critical Care Medicine·Rishi K GuptaIbrahim Abubakar
Jan 18, 2020·American Journal of Respiratory and Critical Care Medicine·Keertan Dheda, Malika Davids
Feb 23, 2020·Annals of the American Thoracic Society·Rishi K GuptaIbrahim Abubakar
Apr 14, 2020·American Journal of Respiratory and Critical Care Medicine·Jason E StoutPatrick P J Phillips
Feb 11, 2020·International Journal of STD & AIDS·Preeti SandhuFrank A Post
Apr 2, 2020·Journal of Clinical Microbiology·Danilo BuonsensoMichela Sali
May 13, 2020·Tuberculosis Research and Treatment·Marie HellebergAase Bengaard Andersen
Mar 3, 2020·Frontiers in Immunology·Charlotte A James, Chetan Seshadri
Mar 29, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jennifer RoeMahdad Noursadeghi
May 28, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Mary R ReichlerUNKNOWN Tuberculosis Epidemiologic Studies Consortium Task Order 2 Team
Feb 21, 2021·EBioMedicine·Cheleka A M MpandeUNKNOWN ACS Study Team
Oct 31, 2020·The European Respiratory Journal·Anna M MandalakasH Lester Kirchner
Apr 24, 2021·The Lancet Infectious Diseases·Katie D DaleJustin T Denholm
Jun 26, 2021·Respiratory Medicine·Francisco Viana MachadoRicardo Reis
Aug 28, 2021·Frontiers in Immunology·Elisa PetruccioliDelia Goletti
Oct 28, 2021·American Journal of Respiratory and Critical Care Medicine·Mahdad Noursadeghi, Rishi K Gupta

❮ Previous
Next ❯